This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.70% per year. These returns cover a period from January 1, 1988 through April 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
growth-investing: Archive
If You Invested $1000 in Caterpillar a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
CATNegative Net Change
growth-investing growth-investors growth-stocks high-growth
3 Reasons Why Growth Investors Shouldn't Overlook Howmet (HWM)
by Zacks Equity Research
Howmet (HWM) is well positioned to outperform the market, as it exhibits above-average growth in financials.
HWMPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
3 Reasons Why Growth Investors Shouldn't Overlook Valmont (VMI)
by Zacks Equity Research
Valmont (VMI) possesses solid growth attributes, which could help it handily outperform the market.
VMINegative Net Change
earnings-growth growth-investing growth-investors growth-stocks
Here is Why Growth Investors Should Buy The Pennant Group (PNTG) Now
by Zacks Equity Research
The Pennant Group (PNTG) possesses solid growth attributes, which could help it handily outperform the market.
PNTGPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
Here is Why Growth Investors Should Buy InfuSystems Holdings (INFU) Now
by Zacks Equity Research
InfuSystems Holdings (INFU) is well positioned to outperform the market, as it exhibits above-average growth in financials.
INFUPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
Atour Lifestyle Holdings Limited Sponsored ADR (ATAT) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Atour Lifestyle Holdings Limited Sponsored ADR (ATAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.
ATATNegative Net Change
earnings-growth growth-investing growth-investors growth-stocks
3 Reasons Why Growth Investors Shouldn't Overlook HealthEquity (HQY)
by Zacks Equity Research
HealthEquity (HQY) possesses solid growth attributes, which could help it handily outperform the market.
HQYPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
3 Reasons Growth Investors Will Love SPX Technologies (SPXC)
by Zacks Equity Research
SPX Technologies (SPXC) could produce exceptional returns because of its solid growth attributes.
SPXCNegative Net Change
earnings-growth growth-investing growth-investors growth-stocks
Ambev (ABEV) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Ambev (ABEV) possesses solid growth attributes, which could help it handily outperform the market.
ABEVPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
Orla Mining (ORLA) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Orla Mining (ORLA) could produce exceptional returns because of its solid growth attributes.
ORLANegative Net Change
earnings-growth growth-investing growth-investors growth-stocks